{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:42:02Z","timestamp":1793295722259,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10067-022-06239-3","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T08:04:43Z","timestamp":1656317083000},"page":"3095-3105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["18F-FDG PET\/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Yuying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1730-9923","authenticated-orcid":false,"given":"Xiangsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"6239_CR1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3389\/fmed.2019.00326","volume":"6","author":"B Hervier","year":"2019","unstructured":"Hervier B, Uzunhan Y (2019) Inflammatory myopathy-related interstitial lung disease: from pathophysiology to treatment. Front Med (Lausanne) 6:326. https:\/\/doi.org\/10.3389\/fmed.2019.00326","journal-title":"Front Med (Lausanne)"},{"key":"6239_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","volume":"60","author":"W Wu","year":"2021","unstructured":"Wu W, Guo L, Fu Y et al (2021) Interstitial lung disease in anti-MDA5 positive dermatomyositis. Clin Rev Allergy Immunol 60:293\u2013304. https:\/\/doi.org\/10.1007\/s12016-020-08822-5","journal-title":"Clin Rev Allergy Immunol"},{"key":"6239_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120313","volume":"10","author":"H Hozumi","year":"2015","unstructured":"Hozumi H, Enomoto N, Kono M et al (2015) Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis\/dermatomyositis-associated interstitial lung disease: a retrospective case control study. PLoS ONE 10:e0120313. https:\/\/doi.org\/10.1371\/journal.pone.0120313","journal-title":"PLoS ONE"},{"key":"6239_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s10067-015-2866-5","volume":"34","author":"J Zou","year":"2015","unstructured":"Zou J, Guo Q, Chi J, Wu H, Bao C (2015) HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients. Clin Rheumatol 34:707\u2013714. https:\/\/doi.org\/10.1007\/s10067-015-2866-5","journal-title":"Clin Rheumatol"},{"key":"6239_CR5","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1093\/rheumatology\/keaa034","volume":"59","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Ye L, Liu M et al (2020) Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis. Rheumatology (Oxford) 59:2829\u20132837. https:\/\/doi.org\/10.1093\/rheumatology\/keaa034","journal-title":"Rheumatology (Oxford)"},{"key":"6239_CR6","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.2967\/jnumed.116.174946","volume":"57","author":"T Nobashi","year":"2016","unstructured":"Nobashi T, Kubo T, Nakamoto Y et al (2016) 18F-FDG uptake in less affected lung field provides prognostic stratification in patients with interstitial lung disease. J Nucl Med 57:1899\u20131904. https:\/\/doi.org\/10.2967\/jnumed.116.174946","journal-title":"J Nucl Med"},{"key":"6239_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13075-021-02578-9","volume":"23","author":"J Liang","year":"2021","unstructured":"Liang J, Cao H, Liu Y et al (2021) The lungs were on fire: a pilot study of (18)F-FDG PET\/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease. Arthritis Res Ther 23:198. https:\/\/doi.org\/10.1186\/s13075-021-02578-9","journal-title":"Arthritis Res Ther"},{"key":"6239_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/14397595.2015.1054099","volume":"26","author":"T Uehara","year":"2016","unstructured":"Uehara T, Takeno M, Hama M et al (2016) Deep-inspiration breath-hold 18F-FDG-PET\/CT is useful for assessment of connective tissue disease associated interstitial pneumonia. Mod Rheumatol 26:121\u2013127. https:\/\/doi.org\/10.3109\/14397595.2015.1054099","journal-title":"Mod Rheumatol"},{"key":"6239_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00259-017-3917-8","volume":"45","author":"T Win","year":"2018","unstructured":"Win T, Screaton NJ, Porter JC et al (2018) Pulmonary (18)F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF). Eur J Nucl Med Mol Imaging 45:806\u2013815. https:\/\/doi.org\/10.1007\/s00259-017-3917-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6239_CR10","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00259-019-04386-5","volume":"46","author":"F Fraioli","year":"2019","unstructured":"Fraioli F, Lyasheva M, Porter JC et al (2019) Synergistic application of pulmonary (18)F-FDG PET\/HRCT and computer-based CT analysis with conventional severity measures to refine current risk stratification in idiopathic pulmonary fibrosis (IPF). Eur J Nucl Med Mol Imaging 46:2023\u20132031. https:\/\/doi.org\/10.1007\/s00259-019-04386-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6239_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347. https:\/\/doi.org\/10.1056\/NEJM197502132920706","journal-title":"N Engl J Med"},{"key":"6239_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626\u2013636. https:\/\/doi.org\/10.1067\/mjd.2002.120621","journal-title":"J Am Acad Dermatol"},{"key":"6239_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188:733\u2013748. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST","journal-title":"Am J Respir Crit Care Med"},{"key":"6239_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2214\/ajr.168.1.8976924","volume":"168","author":"M Akira","year":"1997","unstructured":"Akira M, Hamada H, Sakatani M, Kobayashi C, Nishioka M, Yamamoto S (1997) CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. AJR Am J Roentgenol 168:79\u201383. https:\/\/doi.org\/10.2214\/ajr.168.1.8976924","journal-title":"AJR Am J Roentgenol"},{"key":"6239_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ et al (2015) FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328\u2013354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6239_CR16","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1007\/s00259-010-1490-5","volume":"37","author":"SF Barrington","year":"2010","unstructured":"Barrington SF, Qian W, Somer EJ et al (2010) Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 37:1824\u20131833. https:\/\/doi.org\/10.1007\/s00259-010-1490-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6239_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697\u2013722. https:\/\/doi.org\/10.1148\/radiol.2462070712","journal-title":"Radiology"},{"key":"6239_CR18","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1164\/rccm.2106157","volume":"165","author":"K Ichikado","year":"2002","unstructured":"Ichikado K, Suga M, Muller NL et al (2002) Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am J Respir Crit Care Med 165:1551\u20131556. https:\/\/doi.org\/10.1164\/rccm.2106157","journal-title":"Am J Respir Crit Care Med"},{"key":"6239_CR19","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.chest.2020.04.057","volume":"158","author":"X Lian","year":"2020","unstructured":"Lian X, Zou J, Guo Q et al (2020) Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model. Chest 158:1535\u20131545. https:\/\/doi.org\/10.1016\/j.chest.2020.04.057","journal-title":"Chest"},{"key":"6239_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1148\/radiol.2373041515","volume":"238","author":"K Ichikado","year":"2006","unstructured":"Ichikado K, Suga M, Muranaka H et al (2006) Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases. Radiology 238:321\u2013329. https:\/\/doi.org\/10.1148\/radiol.2373041515","journal-title":"Radiology"},{"key":"6239_CR21","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/rheumatology\/key188","volume":"57","author":"K Kurasawa","year":"2018","unstructured":"Kurasawa K, Arai S, Namiki Y et al (2018) Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis. Rheumatology (Oxford) 57:2114\u20132119. https:\/\/doi.org\/10.1093\/rheumatology\/key188","journal-title":"Rheumatology (Oxford)"},{"key":"6239_CR22","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.ejrad.2016.10.001","volume":"85","author":"V Jacquelin","year":"2016","unstructured":"Jacquelin V, Mekinian A, Brillet PY et al (2016) FDG-PET\/CT in the prediction of pulmonary function improvement in nonspecific interstitial pneumonia. A Pilot Study. Eur J Radiol 85:2200\u20132205. https:\/\/doi.org\/10.1016\/j.ejrad.2016.10.001","journal-title":"Eur J Radiol"},{"key":"6239_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12931-017-0556-3","volume":"18","author":"A Justet","year":"2017","unstructured":"Justet A, Laurent-Bellue A, Thabut G et al (2017) [(18)F]FDG PET\/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis. Respir Res 18:74. https:\/\/doi.org\/10.1186\/s12931-017-0556-3","journal-title":"Respir Res"},{"key":"6239_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13075-021-02460-8","volume":"23","author":"E Ledoult","year":"2021","unstructured":"Ledoult E, Morelle M, Soussan M et al (2021) (18)F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study. Arthritis Res Ther 23:76. https:\/\/doi.org\/10.1186\/s13075-021-02460-8","journal-title":"Arthritis Res Ther"},{"key":"6239_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejrad.2018.08.005","volume":"107","author":"Y Yamanaka","year":"2018","unstructured":"Yamanaka Y, Baba T, Hagiwara E et al (2018) Radiological images of interstitial pneumonia in mixed connective tissue disease compared with scleroderma and polymyositis\/dermatomyositis. Eur J Radiol 107:26\u201332. https:\/\/doi.org\/10.1016\/j.ejrad.2018.08.005","journal-title":"Eur J Radiol"},{"key":"6239_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.rmed.2013.01.014","volume":"107","author":"K Tanizawa","year":"2013","unstructured":"Tanizawa K, Handa T, Nakashima R et al (2013) The prognostic value of HRCT in myositis-associated interstitial lung disease. Respir Med 107:745\u2013752. https:\/\/doi.org\/10.1016\/j.rmed.2013.01.014","journal-title":"Respir Med"},{"key":"6239_CR27","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1378\/chest.12-1359","volume":"143","author":"S El-Chemaly","year":"2013","unstructured":"El-Chemaly S, Malide D, Yao J et al (2013) Glucose transporter-1 distribution in fibrotic lung disease: association with [(1)(8)F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularization. Chest 143:1685\u20131691. https:\/\/doi.org\/10.1378\/chest.12-1359","journal-title":"Chest"},{"key":"6239_CR28","doi-asserted-by":"publisher","first-page":"17070","DOI":"10.1038\/s41598-021-96292-w","volume":"11","author":"W Xu","year":"2021","unstructured":"Xu W, Wu W, Zhang D et al (2021) A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis. Sci Rep 11:17070. https:\/\/doi.org\/10.1038\/s41598-021-96292-w","journal-title":"Sci Rep"},{"key":"6239_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00259-013-2514-8","volume":"41","author":"T Win","year":"2014","unstructured":"Win T, Thomas BA, Lambrou T et al (2014) Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients. Eur J Nucl Med Mol Imaging 41:337\u2013342. https:\/\/doi.org\/10.1007\/s00259-013-2514-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6239_CR30","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/art.24621","volume":"60","author":"S Sato","year":"2009","unstructured":"Sato S, Hoshino K, Satoh T et al (2009) RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum 60:2193\u20132200. https:\/\/doi.org\/10.1002\/art.24621","journal-title":"Arthritis Rheum"},{"key":"6239_CR31","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.ejrad.2016.05.012","volume":"85","author":"Y Waseda","year":"2016","unstructured":"Waseda Y, Johkoh T, Egashira R et al (2016) Antisynthetase syndrome: pulmonary computed tomography findings of adult patients with antibodies to aminoacyl-tRNA synthetases. Eur J Radiol 85:1421\u20131426. https:\/\/doi.org\/10.1016\/j.ejrad.2016.05.012","journal-title":"Eur J Radiol"},{"key":"6239_CR32","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ejrad.2014.11.026","volume":"84","author":"MP Debray","year":"2015","unstructured":"Debray MP, Borie R, Revel MP et al (2015) Interstitial lung disease in anti-synthetase syndrome: initial and follow-up CT findings. Eur J Radiol 84:516\u2013523. https:\/\/doi.org\/10.1016\/j.ejrad.2014.11.026","journal-title":"Eur J Radiol"},{"key":"6239_CR33","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.rmed.2011.05.006","volume":"105","author":"K Tanizawa","year":"2011","unstructured":"Tanizawa K, Handa T, Nakashima R et al (2011) HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med 105:1380\u20131387. https:\/\/doi.org\/10.1016\/j.rmed.2011.05.006","journal-title":"Respir Med"},{"key":"6239_CR34","doi-asserted-by":"publisher","first-page":"779272","DOI":"10.3389\/fmed.2021.779272","volume":"8","author":"H Cao","year":"2021","unstructured":"Cao H, Liang J, Xu D et al (2021) Radiological characteristics of patients with anti-MDA5-antibody-positive dermatomyositis in (18)F-FDG PET\/CT: a pilot study. Front Med (Lausanne) 8:779272. https:\/\/doi.org\/10.3389\/fmed.2021.779272","journal-title":"Front Med (Lausanne)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06239-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T10:29:26Z","timestamp":1663583366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06239-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["6239"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06239-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"13 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of FAHSYSU and was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all patients. For deceased patients, informed consent was obtained from their relatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}